Therapeutic Plasma Exchange in Pediatric Care: Insights from a Tertiary Care Centre Experience

Sphurti Chowdhary1, Krishna Mohan Gulla1, Satya Prakash2

  • 1Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.

Indian Pediatrics
|November 24, 2025
PubMed

Insights

Therapeutic plasma exchange (TPE) is safe and effective for pediatric renal and non-renal conditions, including hemolytic uremic syndrome and autoimmune encephalitis. However, outcomes are impacted by delayed presentation and limited transplant options.

Area of Science:

  • Pediatric Nephrology
  • Pediatric Neurology
  • Pediatric Critical Care

Background:

  • Therapeutic plasma exchange (TPE) is an extracorporeal procedure used for various pediatric conditions.
  • Assessing TPE's safety, efficacy, and outcomes in children is crucial for optimizing treatment strategies.
  • Tertiary care centers play a vital role in managing complex pediatric cases requiring advanced therapies like TPE.

Purpose of the Study:

  • To evaluate the safety, efficacy, and clinical outcomes of therapeutic plasma exchange (TPE) in pediatric patients.
  • To identify patient subgroups that benefit most from TPE and factors influencing outcomes.
  • To analyze the spectrum of indications for TPE in a tertiary care setting.

Main Methods:

  • Retrospective analysis of pediatric patients who underwent TPE between January 2020 and July 2024.
  • Data collection from hospital records at a tertiary care hospital in Eastern India.
  • Analysis of indications, TPE cycles, patient demographics, and outcomes.

Main Results:

  • Forty children underwent 184 TPE cycles; common indications included liver disease (35%), renal diseases (27.5%), and secondary hemophagocytic lymphohistiocytosis (22.5%).
  • Excellent outcomes were observed in autoimmune encephalitis and ASFA category I renal diseases.
  • High mortality was linked to delayed presentation, organ failure, and lack of liver transplant facilities.

Conclusions:

  • Therapeutic plasma exchange (TPE) demonstrates effectiveness in treating pediatric hemolytic uremic syndrome and anti-N-methyl-D-aspartate receptor encephalitis.
  • TPE can be safely and effectively administered for both renal and non-renal indications in children.
  • Optimizing TPE protocols and timely intervention are essential for improving pediatric patient outcomes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
188
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
154
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
231
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
713
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
264
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
171